SBC Medical Group Holdings Inc., a Japanese owner and operator of aesthetic medical clinics, has completed a strategic investment in OrangeTwist, a U.S.-based medspa chain, marking its official entry into the American market. The partnership enables SBC Medical, which manages more than six million patient visits annually through 258 affiliated clinics worldwide, to leverage OrangeTwist's 24 locations across six U.S. states and its advanced management system integrating procurement, clinical workflows, and real-time KPI tracking.
The investment comes as the medical aesthetics industry is forecast to grow from $34 billion today to $48 billion by 2030, driven by demand for non-surgical treatments including injectables, fillers, laser treatments and body contouring. The aging population in the U.S. is also driving demand for these non-invasive treatments. SBC Medical will provide funding and professional know-how to help OrangeTwist enhance its offerings and address "white space" in the U.S. medspa market—cities with high demand for services but few competitors.
Stephen Rodgers, global head of planning and strategy at SBC Medical, told Benzinga that the company plans to make more strategic investments to expand in the U.S., seeking local partnerships rather than copying its Japanese model. In addition to running clinics together, OrangeTwist and SBC Medical plan to jointly develop branded products and sell their existing products in each other's spas.
The partnership positions SBC Medical to capitalize on the broader longevity industry, which is shifting from increasing lifespan to boosting "healthspan" through personalized, preventative and tech-driven solutions. According to Gabelli Research, the global anti-aging market, valued at approximately $85 billion in 2025, is expected to surpass $120 billion by 2030, growing at a CAGR of 7% from 2025-2030. North America accounts for approximately 30% of the market, while robust growth also comes from Asia, where beauty-conscious consumers and an aging population along with affordable products drive demand.
While OrangeTwist gives SBC Medical a foothold in the U.S., the company is also expanding in Japan and Southeast Asia as part of its 2026 growth strategy. The company's global expansion rests on three core tenets: partnering with high-performing regional operators with scalable business models, deploying SBC's expertise to drive efficiencies and optimize operating performance, and securing first-mover advantages to support innovation and margin expansion.
By standardizing services across markets, SBC Medical aims to ensure patients receive consistent high-quality services at similar price points. This approach is being implemented across Japan, Thailand and Singapore as the company pursues its goal of becoming the region's leading provider of aesthetic beauty services. The partnership model allows SBC Medical to create a single, trusted brand that provides aesthetic beauty services across the globe while adapting to local market conditions.
